Helicobacter Pylori Infection - Recent Developments in Diagnosis
Helicobacter Pylori Infection - Recent Developments in Diagnosis
Helicobacter Pylori Infection - Recent Developments in Diagnosis
TOPIC HIGHLIGHT
Ana Isabel Lopes, Centro Académico de Medicina de Lisboa, endoscopic evaluation methodologies for the diagnosis
Faculdade de Medicina da Universidade de Lisboa, 749-016 Lis- of H. pylori infection, such as magnifying endoscopy
boa, Portugal techniques and chromoendoscopy. In addition, the di-
Filipa F Vale, Centro de Patogénese Molecular, Unidade dos agnostic contribution of histology and the urea breath
Retrovírus e Infecções Associadas, Instituto de Medicina Mo-
test was explored recently in specific clinical settings
lecular e Instituto de Investigação do Medicamento, Faculdade
de Farmácia, Universidade de Lisboa, 1749-016 Lisboa, Portu-
and patient groups. Recent studies recommend en-
gal hancing the number of biopsy fragments for the rapid
Mónica Oleastro, Laboratório Nacional de Referência das In- urease test. Bacterial culture from the gastric biopsy is
feções Gastrintestinais, Departamento de Doenças Infeciosas, the gold standard technique, and is recommended for
Instituto Nacional de Saúde Dr Ricardo Jorge, 749-016 Lisboa, antibiotic susceptibility test. Serology is used for initial
Portugal screening and the stool antigen test is particularly used
Author contributions: Lopes AI planned the paper’s general when the urea breath test is not available, while molec-
structure, format and content; all the authors contributed equally ular methods have gained attention mostly for detect-
to the paper and its final revision. ing antibiotic resistance.
Correspondence to: Ana Isabel Lopes, Professor, MD, PhD,
Centro Académico de Medicina de Lisboa, Faculdade de Medici-
© 2014 Baishideng Publishing Group Inc. All rights reserved.
na da Universidade de Lisboa, Av. Professor Egas Moniz, Código
Postal 1649-035 Lisboa, Portugal. [email protected]
Telephone: +351-217-805000 Fax: +351-217-548215 Key words: Helicobacter pylori ; Diagnosis; Endoscopy;
Received: November 9, 2013 Revised: February 28, 2014 Histology; Culture; Urea breath test; Stool antigen test;
Accepted: April 15, 2014 Serology; Molecular methods
Published online: July 28, 2014
Core tip: Considering the importance of a reliable di-
agnosis in the setting of current recommendations for
Helicobacter pylori (H. pylori ) eradication therapy, re-
Abstract cent developments in both invasive and non-invasive
methods may further contribute to improving H. pylori
Considering the recommended indications for Helico-
detection. The manuscript presents an extensive over-
bacter pylori (H. pylori ) eradication therapy and the view of the major advances in endoscopy, histology,
broad spectrum of available diagnostic methods, a
culture, urea breath test, serology, stool tests and mo-
reliable diagnosis is mandatory both before and after
lecular methods, emphasizing their major contributions
eradication therapy. Only highly accurate tests should
and potential shortcomings.
be used in clinical practice, and the sensitivity and
specificity of an adequate test should exceed 90%. The
choice of tests should take into account clinical circum- Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection -
stances, the likelihood ratio of positive and negative recent developments in diagnosis. World J Gastroenterol 2014;
tests, the cost-effectiveness of the testing strategy and 20(28): 9299-9313 Available from: URL: http://www.wjgnet.
the availability of the tests. This review concerns some com/1007-9327/full/v20/i28/9299.htm DOI: http://dx.doi.
of the most recent developments in diagnostic methods org/10.3748/wjg.v20.i28.9299
of H. pylori infection, namely the contribution of novel
A reliable primary diagnosis and control of treatment Invasive/ Reference Antibiotic resistance
success of Helicobacter pylori (H. pylori) infection is crucial noninvasive method detection
for patients with a wide spectrum of H. pylori-related Endoscopy Invasive Yes No
conditions, including uncomplicated or complicated ulcer Histology Invasive Yes No
disease, mucosa associated lymphoid tissue (MALT) lym- Rapid urease test Invasive No No
Culture Invasive Yes Yes
phoma, atrophic gastritis and previous partial gastric re- Molecular methods Both No Yes
section for gastric cancer. Accurate diagnosis of H. pylori Serology Noninvasive No No
infection involves the combined knowledge, effort and Urea breath test Noninvasive No No
research of laboratories, gastroenterologists and patholo- Stool antigen test Noninvasive No No
A B
tem pathological findings have not yet been identified, copy using indigo carmine compared with histology
and the diagnosis of H. pylori infection in the gastric mu- performed according to the Sydney System[7]. Based on
cosa by endoscopic features has not yet been established several indices, the authors obtained a sensitivity of 94%
(Figure 1). In this setting, the Study Group of Japan in the corpus and 88% in the antrum. However, the spec-
Gastroenterological Endoscopy Society for Establishing ificities in the corpus and in the antrum were low (62%
Endoscopic Diagnosis of Chronic Gastritis performed and 52%, respectively). Another study using a Cuban
a prospective multicenter study enrolling 275 patients[8], adult population[11] also aimed to evaluate the diagnostic
investigating the association between endoscopic findings yield of chromoendoscopy with red phenol at 0.1% for
(conventional findings and indigo carmine contrast) and the detection of H. pylori infection against histology. This
histological diagnosis of H. pylori (antrum and corpus). study reported a sensitivity of 72.6% (95%CI: 64.9-79.2)
It was shown that specific endoscopic findings, such as and a specificity of 75.5% (95%CI: 61.9-85.4). The au-
diffuse redness, spotty redness and mucosal swelling as- thors concluded that it might be a useful method to diag-
sessed by conventional endoscopy and swelling of areae nose H. pylori infection in the gastric mucosa, potentially
gastricae by the indigo carmine contrast method, were use- with some specific advantages (topographic localization,
ful for diagnosing H. pylori infection. avoidance of contamination and fast and immediate read-
Cho et al[9] aimed to establish a new classification for ing).
predicting H. pylori-infected stomachs by non-magnifying
standard endoscopy alone. A total of 617 participants
who underwent gastroscopy were enrolled prospectively HISTOLOGY
and a careful close-up examination of the corpus at the Although histology has been considered to be the gold
greater curvature was performed, maintaining a distance standard for H. pylori detection, the influence of clinical
of 10 mm between the endoscope tip and the mucosal practice on the histopathological detection of H. pylori in-
surface. Despite being a monocenter study in which fection has been insufficiently explored. Recognizing that
standard endoscopy was not directly compared with mag- the number and distribution of H. pylori organisms vary
nifying endoscopy, these results suggest two important in patients taking proton pump inhibitors (PPIs), it has
contributions for prediction of H. pylori infection status: been recommended to discontinue PPIs two weeks be-
(1) the observation of gastric mucosal patterns using fore endoscopy and to take biopsies from both the body
standard endoscopy and proposal of a new endoscopic and the antrum.
classification including a normal RAC and three abnor- In a representative study, Lash et al[12] aimed to evalu-
mal mucosal patterns; and (2) an accuracy of prediction ate the yield of different gastric sampling strategies and
of H. pylori positivity at least similar to that reported in to determine the adherence to the Sydney System guide-
magnifying endoscopy studies (sensitivity of 95.2% and lines in a nationwide sample of endoscopists in United
specificity of 82.2%)[10]. In the future, multicenter trials States. Using a database of biopsy records diagnosed at a
comparing standard endoscopy against magnifying en- single pathology laboratory, the results of gastric biopsies
doscopy, including changes in mucosal patterns after H. taken to evaluate gastric inflammatory conditions in pa-
pylori eradication, and including endoscopists with differ- tients with no endoscopic lesions were reviewed. The in-
ent levels of expertise, are needed to confirm the reliabil- cisura angularis, rarely sampled, yielded minimal additional
ity of these data. diagnostic information and the acquisition of at least
Chromoendoscopy has also regained attention re- two biopsy specimens from the antrum and corpus, es-
cently as an additional methodology to detect H. pylori in sentially following the Sydney System recommendations,
the gastric mucosa. A multicenter Japanese study involv- was confirmed as a sensible strategy that guarantees the
ing 275 patients evaluated the possibility of diagnosing maximum diagnostic yield for the most common gastric
H. pylori by conventional endoscopy and chromoendos- inflammatory conditions.
In a Canadian study[13], electronic patient records were for H. pylori, with the lowest rate of inter observer varia-
evaluated for the sites of gastric sampling and PPI use at tion and is much faster than conventional histology[19].
endoscopy, collecting 150 cases with biopsies taken from However, the necessity for routine special stains and/or
both the antrum and body, which were randomly selected IHC stains has been debated in recent years. A recent
for pathological re-review with special stains. The gastric study by Wang et al[20] confirmed what many pathologists
regions sampled, H. pylori distribution and influence of assume: routine special stains, specifically IHC stains, are
clinical factors on pathological interpretation were as- not cost-effective or necessary. Recently, Smith et al[21], in
sessed. This study confirmed that, despite national and a retrospective study involving 200 consecutive gastric
international guidelines for managing H. pylori infection, biopsy specimens, further confirmed that H. pylori is eas-
these guidelines are infrequently adhered to, with PPIs ily observed in the majority of cases with HE (sensitivity
frequently contributing to false diagnosis, and sampling 91% and specificity 100%), remaining the most expedient
only one region increases the likelihood of missing active and least expensive test for identifying H. pylori in gastric
infection by at least 15%. biopsies.
Considering that atrophy of the stomach mucosa An institutional quality assurance study of a conven-
develops in about 50% of H. pylori infected individuals tional method for the diagnosis of H. pylori - associated
by the age of 65, and is considered a pre-malignant le- gastritis was performed by Hartman et al[22] in the United
sion for gastric cancer[14-16], H. pylori eradication is recom- States, based on head-to-head evaluation by four meth-
mended in the presence of atrophy[17], because atrophy ods, HE stain, Giemsa stain, Warthin-Starry stain, and H.
may reverse after successful eradication therapy. It is pylori immunostaining of 356 gastric biopsy specimens.
critically important and challenging, therefore, to deter- About 83% of H. pylori gastritis identified were diag-
mine the presence or absence of H. pylori in patients with nosed on the initial HE-stained slides, further supporting
atrophic gastritis. During atrophy progression, however, the use of routine ancillary stains to diagnose H. pylori
the density of H. pylori in the stomach mucosa decreases, infection in gastric biopsy specimens. Usually, the use of
and may disappear completely during the late stages of special stains is only recommended for biopsy specimens
atrophy[14,16]. This may explain the markedly lower sen- with moderate to severe chronic active or inactive gastri-
sitivity of biopsy-based tests (RUT, histology, culture) tis in which H. pylori is not identified by HE staining, for
in the presence of atrophy. Similarly, UBT and antigen post-treatment biopsy specimens and in cases in which
stool detection can also give false-negative results in these structures “suspicious”, but not definitive, for H. pylori
circumstances. In contrast, serology is not influenced to are observed by HE staining[23].
such an extent by a lower density of the microorganism, Both routine conventional histology-based methods
and is reliable even in advanced gastric body atrophy[14,16]. and novel methods for H. pylori detection have increas-
Maastricht guidelines updates have reserved serology ingly focused on specific clinical settings and patient
for special situations, including extensive atrophy of the groups (bleeding peptic ulcer, gastric cancer). False-
stomach mucosa on the basis that other tests might be negative results may occur when using histological and
misleading at a low bacterial density. Thus, the debate RUT to detect H. pylori in biopsy specimens obtained
continues regarding the most appropriate H. pylori diag- during peptic ulcer bleeding episodes (PUB). Choi et al[24]
nostic method in atrophic gastritis. evaluated different diagnostic methods in the specific
Lan et al[18] aimed to evaluate the site and sensitivity setting of peptic ulcer, concluding that histology was the
of biopsy-based tests in terms of degree of gastritis with most accurate test, regardless of bleeding, compared with
atrophy. Biopsy-based tests (i.e., culture, histology Giemsa culture, serology and RUT. Ramirez-Lazaro et al[25] found
stain and RUT) and non-invasive tests (anti-H. pylori IgG) that IHC and real-time PCR methods might improve the
were performed in 164 uninvestigated dyspepsia patients. sensitivity of biopsy-based diagnosis in this specific set-
The sensitivity of biopsy-based tests decreased when the ting (PUB).
degree of gastritis with atrophy increased, regardless of In patients submitted to a subtotal gastrectomy due
biopsy site. In moderate to severe antrum or body gastri- to gastric cancer, the identification and treatment of
tis with atrophy, additional corpus biopsy increased the H. pylori are the key points in the prevention of cancer
sensitivity to 16.67%, as compared with single antrum recurrence. Xu et al[26] evaluated the predictive value of
biopsy. These results confirm that in moderate to severe neutrophil infiltration, a hallmark of active inflammation
gastritis with atrophy, biopsy-based test should include (updated Sydney system), as a histological marker of H.
the corpus for avoiding false negative results in H. pylori pylori infection, in 315 dyspeptic patients undergoing up-
detection. per gastrointestinal endoscopy, including patients with a
Since the discovery of H. pylori, pathologists have subtotal gastrectomy. The diagnosis of H. pylori infection
used different diagnostic techniques, including immu- was based on UBT and on anti-H. pylori immunoglobulin
nohistochemical (IHC) methods and special stains, such G (IgG) antibody in patient with a subtotal gastrectomy.
as Giemsa and Warthin-Starry, on an institution- and Although neutrophil infiltration of gastric mucosa was
laboratory-dependent basis (with variable sensitivities and strongly associated with overall H. pylori infection, in pa-
specificities for identifying H. pylori). On the other hand, tients with a subtotal gastrectomy, the diagnostic accuracy
it is clear that IHC staining is highly sensitive and specific of neutrophil infiltration in H. pylori infection was low.
cella, Columbia Wilkins-Chalgren, brain-heart infusion or possibly acting as a “reservoir” contributing to the intra-
trypticase agar bases, supplemented with sheep or horse familial spread[50].
blood[39]. An alternative to blood is supplementation of
the agar base with b-cyclodextrin or yolk emulsion[40,41].
The most recent advances on H. pylori culture concern MOLECULAR METHODS
growth medium composition, besides the usual serum or Diagnostics tests rely more and more on molecular tests,
blood additives. A recent study showed that supplemen- which can provide faster, more accurate and sensitive
tation of media with cholesterol instead of serum was detection of the bacterium than conventional methods,
a viable option for H. pylori growth[42]. Another original with the possibility of extension to other purposes, such
approach used liquid culture medium for the rapid cul- as detection of antibiotic resistance and virulence de-
tivation and subsequent antibiotics susceptibility testing terminants, and bacterial quantification. Moreover, bio-
of H. pylori directly from biopsy specimens, with a final logical samples other than gastric biopsies can be used,
detection step by an enzyme linked immunosorbent assay obtained using less invasive methods, such as stool or
(ELISA)[43]. oral cavity samples. Whatever the case, amplification of
Concerning the growth atmosphere, H. pylori is a cap- the nucleic acids by PCR is almost always present, either
nophilic organism that requires an atmosphere enriched conventional PCR or, increasingly, by real-time PCR.
with CO2 (varying from 5%-10%). In addition, it has H. pylori, like a few other bacteria, acquires resistance
been considered a microaerophile, but there is no general by mutation, which has enabled the development of
consensus about its specific O2 requirements[44]. A recent numerous assays, in several formats, to detect mutations
advance on this topic was made by Park et al[45], who leading to resistance, especially to macrolides and fluoro-
showed that unlike previous reports, H. pylori may be a quinolones. To detect H. pylori and resistances to fluoro-
capnophilic aerobe whose growth is promoted by atmo- quinolones and clarithromycin, there is a multiplex PCR
spheric oxygen levels in the presence of 10% CO2. followed by a hybridization and alkaline phosphatase
Typically, culture of H. pylori is performed on gastric reaction on a membrane strip (the Genotype® HelicoDR
biopsy samples, and because bacteria display an irregular kit), that uses as a starting material biopsy specimens, as
distribution in the gastric mucosa, culture of more than well as culture material extracted from it. The test shows
one biopsy, from the antrum and corpus, is sometimes a high sensitivity and permits detecting infection with
mandatory, especially after antibiotic treatment. Another multiple strains. The performance in detecting fluoroqui-
important issue to bear in mind are factors that may af- nolone-resistance strains was, however, lower than cul-
fect the outcome of H. pylori culture from endoscopic ture, emphasizing the need to expand the range of gyrA
gastric mucosal specimens. Besides the issue concern- mutations included in the kit[51,52]. Several real-time PCR
ing bleeding peptic ulcers, for which culture has a lower based assays, using either TaqMan or FRET (Fluorescence
sensitivity than in nonbleeding cases, other host-related Resonance Energy Transfer) are available, as in-house
factors, such as high activity of gastritis, low bacterial assays or commercial kits, for clarithromycin resistance,
load, drinking alcohol and the use of histamine H2 recep- performed on cultured strains, directly on biopsies[53-55] or
tor blockers, have been recently described as the cause of in stool samples. The latter is particularly useful as a non-
failed H. pylori culture from gastric mucosa in the infected invasive test in pediatric populations, where a high preva-
subjects[24,46]. lence of clarithromycin-resistant strains is suspected,
Culturing from stools has been shown to be extreme- as well as for tracking the emergence of clarithromycin
ly difficult because of the complex nature of the sample resistance following eradication treatment[57,58].
regarding microbiota composition and shedding of unvi- Recently, a dual-priming oligonucleotide (DPO)-based
able H. pylori cells, and this technique has been successful multiplex PCR was developed to detect both H. pylori
in the setting of rapid gastrointestinal tract transit[47]. In infection and the most common point mutations confer-
a recent study, the authors were able to culture H. pylori ring resistance to clarithomycin, directly on gastric biopsy
in nine and 12 rectal and ileal fluids, respectively, after specimens. This assay proved to be fast and does not
polyethylene glycol (colyte) ingestion in 20 healthy adults require expensive instrumentation, making it valuable in
with positive UBT[48]. Other studies have looked for the countries with a high prevalence of clarithromycin resis-
role of the oral cavity as a reservoir of H. pylori. A recent tance[59,60].
work evaluated the occurrence of the organism in subgin- The detection of clarithromycin-resistance from for-
gival plaque and was able, by culture, to recover H. pylori malin-fixed, paraffin-embedded gastric biopsies has also
in nine of 30 studied patients that were H. pylori positive been described, and is useful mostly before treatment
with RUT and histopathological examination. Thus, they when culture and susceptibility testing is not available, or
concluded that detection of H. pylori in dental plaque of to detect primary resistance to clarithromycin in the case
dyspeptic patients cannot be neglected and might repre- of failure of an empirical therapy based on this antibiotic.
sent a risk factor for recolonization of the stomach after Real-time PCR assays, as well as a peptide nucleic acid-
systemic eradication therapy[49]. The same conclusion was fluorescence in situ hybridization (PNA-FISH) method,
reached by another study in which H. pylori was detected have been described recently[61-63].
in subgingival dental plaque of children and their families, Another area of particular interest is the detection
of virulence determinants, such as the cagA (cytotoxin- towards understanding the pathways that are associated
associated gene A) and the vacA (vacuolating cytotoxin) with the respective disease, contributing to the identifica-
major toxins. Several studies showed that the risk of tion of novel therapeutic or diagnostic targets.
progression of gastric preneoplastic lesions is higher in Our current knowledge on the proteome of this or-
patients infected with strains harboring the most virulent ganism is largely based on data obtained for the soluble
cagA and vacA genotypes than in patients infected with proteome[73], membrane proteome[74,75] and secreted pro-
the least virulent strains. Therefore, H. pylori genotyping teome[76] of strain 26695, the first isolate to be sequenced.
may be useful to identify patients at high risk of progres- More recently, relevant contributions have made been
sion of gastric preneoplastic lesions and who need more through this approach, such as novel biomarkers for gas-
intensive surveillance[64]. Concerning vacA, a novel meth- tric cancer and for peptic ulcer disease[77,78].
od for genotyping the vacA intermediate gene region
was reported recently, using a novel primer combination
allowing the amplification of smaller DNA fragments NONINVASIVE TESTS
than the original PCR, which can therefore be applied to Although the reliability of both the 13C-UBT and a
paraffin-embedded biopsies. Patients infected with vacA monoclonal ELISA stool test (HpSA) to diagnose H. py-
i1 strains showed an increased risk of gastric atrophy and lori infection in very young children has been confirmed,
gastric carcinoma, with odds ratios of 8.0 (95%CI: 2.3-27) additional background information is warranted for epi-
and of 22 (95%CI: 7.9-63)[65]. demiological studies in infants and toddlers.
CagA undergoes phosphorylation on tyrosines within
the Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs at the poly-
morphic C-terminus[66]. Several studies suggest a role for UREA BREATH TESTS
the polymorphic CagA EPIYA-containing region in the The 13 C-urea breath test (13C-UBT) is one of the most
pathogenicity of H. pylori, although conflicting results reliable tests for diagnosing H. pylori infection. It is a
have been reported[67,68]. The in vivo role of this region non-invasive, simple and safe test that provides excellent
was emphasized recently in a study showing that infection accuracy both for the initial diagnosis of H. pylori infec-
with strains harboring two or more CagA EPIYA C mo- tion and for the confirmation of its eradication after
tifs was associated with the presence of surface epithelial treatment. The simplicity, good tolerance and economy
damage, and with atrophic gastritis and gastric carcinoma. of the citric acid test meal probably make its systematic
Moreover, the presence of two or more CagA EPIYA C use advisable. The UBT protocol may be performed with
motifs increased the risk of atrophic gastritis from 7.3 relatively low doses (< 100 mg) of urea: 75 mg or even
(95%CI: 2.1-25) to 12 (95%CI: 2.5-58) and of gastric car- 50 mg seem to be sufficient. With the most widely used
cinoma from 17 (95%CI: 5.4-55) to 51 (95%CI: 13-198), protocol (with citric acid and 75 mg of urea), excellent
when compared with one EPIYA C motif. Therefore, ge- accuracy is obtained when breath samples are collected
notyping H. pylori virulence determinants could represent as early as 10-15 min after urea ingestion. A unique and
a useful approach in defining severe gastric-disease risk. generally proposed cut-off level is not possible, because
Bacterial quantification can also be important for it has to be adapted to different factors, such as the test
clinical management of the infection; for example, for meal, the dose and type of urea, or the pre-/post-treat-
monitoring the treatment outcome or in particular set- ment setting. As positive and negative UBT results tend
tings, such as upper gastrointestinal bleeding[69]. to cluster outside of the range between 2 and 5, a change
A recently developed real-time quantitative PCR assay in cut-off value within this range would be expected to
based on H. pylori ureC (single copy gene) copy number have little effect on the clinical accuracy of the test[79,80].
proved to be around 10 times more sensitive than the UBT is now marketed for use with a nondispersive,
conventional PCR method. Moreover, the copy number isotope-selective infrared spectroscope or laser-assisted
of ureC was significantly increased when overall gastritis, ratio analysis, which are reliable and valid alternatives to
bacterial density, chronic inflammation and intestinal isotope ratio mass spectrometry (IRMS) of potential in-
metaplasia were present[70]. Nevertheless, further studies terest for epidemiologic studies of children, for screening
are necessary to determine the optimum cut-off point, symptomatic children before endoscopy or assessment
making it possible to differentiate between asymptom- of treatment efficacy. These devices are far smaller and
atic colonization and infection with clinical implications cheaper, and they allow for in-office, near-immediate
for patients. These highly sensitive real-time quantitative reading of results. Validation studies to establish the cut-
PCRs can have a large application on the study of envi- off value for this test were preliminarily performed in
ronmental reservoirs as well[71,72]. Japan[81]; however, further data are needed[82,83].
By improving our knowledge of bacteria, at the mo- The 13 C-UBT in adults has a high sensitivity
lecular level, new strategies for treatment/prevention of (88%-95%) and specificity (95%-100%)[17]. However, the
bacterial-associated diseases, as well as diagnostic tests, test has shown heterogeneous accuracy in the pediatric
can be developed. Proteomic approaches aimed at identi- population, especially in young children, with values of
fying gene products differentially expressed in association sensitivity and specificity ranging from 75% to 100%,
with a given pathology can provide an important input before and after treatment (using several protocols),
despite being a simple and safe non-invasive test in chil- Pacheco et al[92] evaluated the diagnostic accuracy of
dren older than 6 years old[84]. Although several modifi- detecting H. pylori infection of low dose 13C-UBT with
cations have been proposed since the original descrip- early sampling at pediatric age (129 patients between the
tion by Graham of the 13C-UBT to diagnose H. pylori ages of 2.1 and 19 years old, median = 11.6 years) sub-
infection[85], in children, performance criteria are not yet mitted to upper gastrointestinal endoscopy. The 13C-UBT
sufficiently established[86]. In the specific age group of was performed after a 4-h fasting period with four points
younger children, accurate non-invasive tests for diag- of collection: baseline (T0, at 10, 20 and 30 min) after
nosing H. pylori infection are required, as they may avoid ingestion of 25 mg 13C-urea diluted in 100 mL of apple
invasive and painful procedures, such as endoscopy and juice; analysis of exhaled breath samples was performed
blood sampling, and to overcoming the false negative with an isotope-selective infrared spectrometer. The sen-
results observed with gold standard tests (histology, cul- sitivity and specificity were similar at T10, T20 and T30
ture, and RUT), where colonization of the stomach may (94.7%/96.8%; 96.2%/96.1% and 96.2%/94.7%, respec-
be weak and patchy. tively).
Potential explanations for UBT performance vari- Recently, Queiroz et al[93] investigated the agreement
ability in children might include: (1) urease activity from between the 13C-UBT and a monoclonal ELISA (HpSA)
the oral bacterial flora[87]; (2) differences in delta time to detect H. pylori antigen in stool in a prospective study
(decrease in specificity if samples obtained at 15 min in- enrolling 414 South-American infants (123 from Brazil
stead of 30 min); and (3) variability in cut-off values. The and 291 from Peru) aged 6-30 mo. Breath and stool sam-
administration of 13C-urea in capsules to avoid activity of ples were obtained at intervals of at least three-months.
13
oral bacteria, though effective in adults, is not feasible in C-UBT and stool test results concurred with each other
infants or toddlers[88]. Finally, the cut-off value (usually in 94.86% cases (kappa coefficient = 0.90, 95%CI: 87-92).
determined by a ROC curve) represents a crucial factor In the H. pylori-positive group, DOB and OD values were
for the accuracy of the test, where low cut-off values positively correlated (r = 0.62, P < 0.001, suggesting that
might increase sensitivity but reduce specificity, and vice both 13C-UBT and stool monoclonal test are reliable to
versa[81]. Additionally, the individual’s CO2 production is diagnose H. pylori infection in very young children.
influenced by anthropometric characteristics, as well as by In contrast to pediatric studies, where attention has
age and sex (lower in young children with relatively low been focused on methodological issues, in adult studies,
weight and height)[89]. the validity and usefulness of UBT have increasingly been
Leal et al [90] performed an informative systematic evaluated in a wide spectrum of specific clinic settings.
review and meta-analysis (31 articles and 135 studies Olafsson et al[94] evaluated 620 UBT in 595 subjects at a
from January 1998 to May 2009), aiming to evaluate the gastroenterology clinic. UBT was negative in 526 patients,
performance of the 13C-UBT diagnostic test for H. pylori but: (1) 45% patients were tested < 4 wk before the end
infection in children. Studies with at least 30 children of treatment; and (2) 23% of negative results occurred
and reporting the comparison of 13C-UBT against a gold in patients recently treated. The authors emphasized the
standard for H. pylori diagnosis (H. pylori culture, histo- need for strict protocol adherence in clinical practice for a
logic examination, or RUT) were included for analysis. fully reliable UBT assessment. Velayos et al[95] investigated
Children were stratified in subgroups of < 6 and ≥ 6 the accuracy of UBT performed immediately after emer-
years of age. The 13C-UBT performance meta-analyses gency endoscopy in 74 patients with peptic ulcer bleeding
showed: (1) good accuracy in all ages combined [sensitiv- by comparing the results with those of UBT performed
ity 95.9%, specificity 95.7%, diagnostic odds ratio (DOR) after hospital discharge in a subset of 53 patients (gold
424.9]; (2) high accuracy in children > 6 years (sensitivity standard). Although UBT carried out immediately after
96.6%, specificity 97.7%, DOR 1042.7); and (3) greater emergency endoscopy in peptic ulcer bleeding is an ef-
variability in accuracy estimates and a lower specificity fective, safe and easy-to-perform procedure, the relatively
in children ≤ 6 years (sensitivity 95%, specificity 93.5%, low sensitivity and specificity suggested the requirement
DOR 224.8). The authors identified as potentially impor- of a subsequent control, in accordance with recommen-
tant sources of heterogeneity: (1) tracer dose; (2) pretest dations concerning peptic ulcer bleeding[96].
meal; and (3) cut-off value, observing that a unique Few studies using UBT have been performed in pa-
tracer dose of 50 mg of 13C-urea showed greater accu- tients subjected to a partial gastrectomy, a specific group
racy when it was adjusted to body weight (50-75 mg were in which the identification of H. pylori infection is mostly
used between studies). Accordingly, Mégraud[91] previ- relevant. Wardi et al[97] evaluated the sensitivity and speci-
ously reported that reducing the dose from 75 to 45 mg ficity of the continuous UBT (BreathID) in 76 post gas-
in younger children resulted in improved specificity. Al- trectomized patients (older than 18 years) (lowering the
though citric acid has demonstrated good performance in gastric pH by the addition of citric acid), against RUT
adults, it is not well accepted by children, and apple, or- and histology as gold standards. H. pylori was positive in
ange, or grape juice seem to be good alternatives. Finally, 14/76 (18.4%) patients when histology was considered as
a cut-off value of 6.0‰ improved overall performance in the gold standard method. The positive predictive values
children younger than 6 years, as compared to a cut-off of the continuous UBT and the RUT were 0.64 and 0.35,
of 4.0 ‰ for children older than 6 years. respectively. The negative predictive value was high by
both the methods, 0.92 and 0.95, respectively, supporting nal lateral flow chromatography (LFC); Meridian Biosci-
the view that BreathID might have some reliability to ex- ence, Europe Srl Milano, Italy); the H. pylori fecal antigen
clude H. pylori after partial gastrectomy. test (based on monoclonal LFC; Vegal Farmaceutica, Ma-
drid, Spain) and the one-step H. pylori antigen (based on
LFC with polyclonal antibodies; IHP-602, ACON Labo-
STOOL ANTIGEN TESTS ratories, Inc, San Diego, United States). Data comparison
The stool antigen test is a non-invasive method to detect showed an uneven performance, favoring the Premier
H. pylori, usually recommended when the UBT is not Platinum HpSA Plus test (sensitivity 92.2%; specificity
available[98]. Besides being non-invasive, the advantages 94.4%). The selection of the stool antigen assay is very
of using this method include the unneeded requirement important to achieve accurate results.
of expensive equipment and medical personnel, and the Stool antigen tests are also useful to detect H. pylori in
collection of the sample at home without a visit to the infected animal models, such as C57BL/6 mice[105].
hospital. This method is especially relevant for children’s
access to a safe diagnosis and also for its low cost[99,100].
A meta-analysis revealed that the global sensitivity and Antibody - based tests
specificity of stool antigen tests are 94% (95%CI: 93-95) Serology was one of the first methods used for diagnosis
and 97% (95%CI: 96-98), respectively[101]. A prospective of H. pylori infection[106]. Currently, serology is recom-
study to evaluate the efficacy of a new EZ-STEP H. py- mended for initial screening, requiring further confirma-
lori polyclonal enzyme immunoassay (EIA) stool antigen tion by histology and/or culture before treatment [107].
test enrolled 555 patients undergoing routine checkups. Detection of antibodies is useful for detecting past or
At the optimal cut-off value (optical density 0.160), this present exposure. In fact, a limitation of serology tests
test presented high level of sensitivity (93.1%), specificity is the failure to distinguish between past and current H.
(94.6%) and accuracy (93.8%)[99]. pylori infection[99]. Moreover, the antibody levels to H.
There are two types of stool antigen tests used for pylori are significantly heritable. Thus, individual genetic
H. pylori detection, the EIA and an assay based on immu- differences of the human host contribute substantially to
nochromatography. Two new stool tests were developed antibody levels to H. pylori[108].
recently[102]. These tests are the Testmate pylori antigen Serological tests have several advantages, namely they
EIA, in which plastic 96-well EIA microtiter plates are are non-invasive and they do not produce false negative
coated with monoclonal antibody (Mab) 21G2[103], and results in patients receiving treatment (proton pump in-
the Testmate rapid pylori antigen, which is based in im- hibitors and antibiotics) or presenting acute bleeding[109].
munochromatography and is presented as a test strip. For Blood samples are used for serology testing, detect-
the EIA test, a drop of the suspended stool sample or a ing anti-H. pylori antibodies (IgG) by ELISA. Recently,
sample of the diluted bacterial antigen sample is mixed the performance of 29 different serological tests kits was
with the peroxidase-conjugated MAb 21G2. After proper compared, revealing sensitivities ranging from 55.6% to
incubation and washing, the optical density is measured 100%, specificities ranging from 59.6% to 97.9 %, posi-
and considered positive if greater than 0.100. For the test tive predictive values ranging from 69.8% and 100%,
strip, a drop of stool sample is applied in the specimen and negative predictive values ranging from 68.3% and
application of the test strip. When H. pylori antigens are 100%[106]. According to the goal, such as screening, initial
present, they form immune complexes with the red latex- diagnosis and confirmation of another test, the most ap-
labeled MAb 21Ge and migrate by capillarity action until propriate kit should be chosen. Antibody-based tests for
captured by the solid phase anti-mouse rabbit polyclonal the detection of H. pylori are easily available, but present
antibodies and form a visible red test line. A control line high negative predictive value[110]. The heterogeneity of H.
is also present. After application of these tests to 111 pylori strains has been well documented, with considerable
stool samples, both new tests provide 100% specific- variation in the prevalence of specific strains, especially
ity, sensibility and accuracy[102], which is very promising. from different geographical areas[111-113]; thus, the success
However, not all studies report these high values for sen- of a serology test depends on the use of antigens that
sitivity and specificity. For example, the report of Chehter are present in H. pylori strains from a given population.
et al[100] analyzed the stools of 75 patients and determined Moreover, kits developed using H. pylori strains from
a lower sensitivity (87.2%) and specificity (44%); Irani- the west are not suitable for detecting H. pylori infection
khah et al[104] analyzed the stools of 103 children and ob- in the East[114]. The use of high-molecular-weight cell-
tained similar values for sensitivity (85%), but improved associated antigens that are conserved in H. pylori strains
specificity (83%). overcomes this limitation[115]. Several H. pylori immuno-
Recently, five different stool antigen tests were com- genic proteins have been presented as candidates to de-
pared: the Premier Platinum HpSA Plus test (based on tect infection, such as the FlidD protein[116]; multiple re-
monoclonal EIA; Meridian Bioscience, Inc, Cincinnati, combinant (CagA, VacA, GroEL, gGT, HcpC and UreA)
OH, United States); the Hp Ag test (based on monoclo- proteins[116]; CagA[115] or Omp18[117].
nal EIA; Dia.Pro Diagnostic Bioprobes Srl, Milano, Italy); Modifications to serology tests have been suggested,
the ImmunoCard STAT! HpSA test (based on monoclo- such as the automated immunoaffinity assay for H. pylori
IgG detection using purified antigen of H. pylori immobi- versus adults) and clinical conditions, such as peptic ulcer
lized on magnetic nanobeads, which is faster than ELISA bleeding, atrophic gastritis, post-gastrectomy status, as
and requires a smaller volume of serum[118]. The lateral well as for wider application in epidemiological studies.
flow immunoassay, an immunochromatographic assay, The specific contribution of each method to the evolving
maintains the serological approach with the advantage of strategies and algorithms for evaluation and management
being fast, economic and requiring no additional equip- of H. pylori infection (test and treat) will remain of para-
ment or experience[119]. mount relevance.
Detection of gastrin and the serum PG Ⅰ/Ⅱ ratio
combined with H. pylori serology is useful to predict
gastric preneoplastic conditions[110]. The PG Ⅰ/Ⅱ ratio REFERENCES
decreases with advancing extensive atrophic gastritis, 1 Watanabe K, Nagata N, Shimbo T, Nakashima R, Furuhata E,
since PG I is produced by chief and mucous neck cells in Sakurai T, Akazawa N, Yokoi C, Kobayakawa M, Akiyama J,
Mizokami M, Uemura N. Accuracy of endoscopic diagnosis
the fundus glands, which are impaired in case of gastritis of Helicobacter pylori infection according to level of endo-
of the fundus; while PG Ⅱ is produced by the former scopic experience and the effect of training. BMC Gastroen-
cells and also by cardiac, pyloric and duodenal Brunner’s terol 2013; 13: 128 [PMID: 23947684 DOI: 10.1186/1471-230X-
glands[120]. 13-128]
2 Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T,
Mukoubayashi C, Deguchi H, Enomoto S, Ueda K, Maekita T,
DETECTION OF H. PYLORI IN OTHER Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro
M, Iwane M, Tekeshita T, Mohara O, Ushijima T, Ichinose M.
SPECIMENS Development of gastric cancer in nonatrophic stomach with
highly active inflammation identified by serum levels of
Other specimens have been evaluated to determine their pepsinogen and Helicobacter pylori antibody together with
usefulness to detect H. pylori infection. These include sa- endoscopic rugal hyperplastic gastritis. Int J Cancer 2012; 131:
liva[121,122], subgingival biofilm[123], dental plaque[124], gastric 2632-2642 [PMID: 22383377 DOI: 10.1002/ijc.27514]
juice, gastroesophageal biopsies[125] and adenotonsillar 3 Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Oka-
moto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of
tissue[126]. Contradictory results have been reported re- eradication of Helicobacter pylori on incidence of metachro-
garding H. pylori detection in adenotonsillar tissue, either nous gastric carcinoma after endoscopic resection of early
favoring[127] or against[126] adenotonsillar tissue as an extra- gastric cancer: an open-label, randomised controlled trial.
gastric reservoir of H. pylori. The ability to detect H. pylori Lancet 2008; 372: 392-397 [PMID: 18675689 DOI: 10.1016/
antibodies in saliva is lower than in blood-based serology. S0140-6736(08)61159-9]
4 Lee JH, Park YS, Choi KS, Kim do H, Choi KD, Song HJ,
However, the use of molecular techniques for the detec- Lee GH, Jang SJ, Jung HY, Kim JH. Optimal biopsy site
tion of H. pylori infection in saliva or dental plaque may for Helicobacter pylori detection during endoscopic mu-
make these specimens attractive because they are easier to cosectomy in patients with extensive gastric atrophy. He-
collect[114]. The molecular techniques include PCR[122,123] licobacter 2012; 17: 405-410 [PMID: 23066901 DOI: 10.1111/
and PCR-denaturing gradient gel electrophoresis (PCR- j.1523-5378.2012.00972.x]
5 Yagi K, Nakamura A, Sekine A. Characteristic endoscopic
DGGE)[128]. Other techniques used to analyze these spec-
and magnified endoscopic findings in the normal stom-
imens are the RUT, immunohistochemistry and PNA- ach without Helicobacter pylori infection. J Gastroenterol
FISH[126]. Hepatol 2002; 17: 39-45 [PMID: 11895551 DOI: 10.1046/
The enterotest or string test was designed decades j.1440-1746.2002.02665.x]
ago specially for children. The string test consists of a 6 Yagi K, Honda H, Yang JM, Nakagawa S. Magnifying endos-
copy in gastritis of the corpus. Endoscopy 2005; 37: 660-666
gelatin capsule attached to a 90-140 cm long nylon string
[PMID: 16010611 DOI: 10.1055/s-2005-861423]
that unwinds during ingestion. Upon reaching the stom- 7 Gonen C, Simsek I, Sarioglu S, Akpinar H. Comparison
ach, the gelatin capsule dissolves and the string absorbs of high resolution magnifying endoscopy and standard
gastric secretions. The extraction of the string occurs videoendoscopy for the diagnosis of Helicobacter pylori
30-180 min later and should avoid contact with teeth and gastritis in routine clinical practice: a prospective study.
Helicobacter 2009; 14: 12-21 [PMID: 19191891 DOI: 10.1111/
tongue to prevent contamination. The string may be used
j.1523-5378.2009.00650.x]
for culture (sensitivity 65% and specificity 99%) or PCR 8 Kato T, Yagi N, Kamada T, Shimbo T, Watanabe H, Ida K.
(sensitivity 79% and specificity 99%) for H. pylori detec- Diagnosis of Helicobacter pylori infection in gastric mucosa
tion[129]. by endoscopic features: a multicenter prospective study.
Dig Endosc 2013; 25: 508-518 [PMID: 23369058 DOI: 10.1111/
den.12031]
CONCLUSION 9 Cho JH, Chang YW, Jang JY, Shim JJ, Lee CK, Dong SH, Kim
HJ, Kim BH, Lee TH, Cho JY. Close observation of gastric
Recent developments in both biopsy- and non-biopsy- mucosal pattern by standard endoscopy can predict Helico-
based diagnostic methods for H. pylori infection will bacter pylori infection status. J Gastroenterol Hepatol 2013; 28:
further contribute to improving current clinical approach 279-284 [PMID: 23189930 DOI: 10.1111/jgh.12046]
and management of H. pylori-associated diseases. 10 Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M,
Arisawa T, Hirata I. Gastric mucosal pattern by using magni-
We predict that in the future, standard and newer fying narrow-band imaging endoscopy clearly distinguishes
methods will evolve to improve the diagnostic yield of H. histological and serological severity of chronic gastritis.
pylori infection detection in specific age groups (children Gastrointest Endosc 2009; 70: 246-253 [PMID: 19386303 DOI:
616-622 [PMID: 12717085 DOI: 10.1097/00005176-200305000- 54 Burucoa C, Garnier M, Silvain C, Fauchère JL. Quadruplex
00005] real-time PCR assay using allele-specific scorpion primers for
40 Olivieri R, Bugnoli M, Armellini D, Bianciardi S, Rappuoli R, detection of mutations conferring clarithromycin resistance
Bayeli PF, Abate L, Esposito E, de Gregorio L, Aziz J. Growth to Helicobacter pylori. J Clin Microbiol 2008; 46: 2320-2326
of Helicobacter pylori in media containing cyclodextrins. J [PMID: 18463216 DOI: 10.1128/JCM.02352-07]
Clin Microbiol 1993; 31: 160-162 [PMID: 8417026] 55 Scaletsky IC, Aranda KR, Garcia GT, Gonçalves ME,
41 Westblom TU, Madan E, Midkiff BR. Egg yolk emulsion Cardoso SR, Iriya K, Silva NP. Application of real-time
agar, a new medium for the cultivation of Helicobacter py- PCR stool assay for Helicobacter pylori detection and
lori. J Clin Microbiol 1991; 29: 819-821 [PMID: 1890184] clarithromycin susceptibility testing in Brazilian children.
42 Jiménez-Soto LF, Rohrer S, Jain U, Ertl C, Sewald X, Haas Helicobacter 2011; 16: 311-315 [PMID: 21762271 DOI: 10.1111/
R. Effects of cholesterol on Helicobacter pylori growth and j.1523-5378.2011.00845.x]
virulence properties in vitro. Helicobacter 2012; 17: 133-139 56 Oleastro M, Cabral J, Ramalho PM, Lemos PS, Paixão E,
[PMID: 22404444 DOI: 10.1111/j.1523-5378.2011.00926.x] Benoliel J, Santos A, Lopes AI. Primary antibiotic resistance
43 Perna F, Vaira D. A new 24 h ELISA culture based meth- of Helicobacter pylori strains isolated from Portuguese chil-
od for Helicobacter pylori chemosusceptibility. J Clin dren: a prospective multicentre study over a 10 year period.
Pathol 2010; 63: 648-651 [PMID: 20515875 DOI: 10.1136/ J Antimicrob Chemother 2011; 66: 2308-2311 [PMID: 21764826
jcp.2010.076844] DOI: 10.1093/jac/dkr293]
44 Bury-Moné S, Kaakoush NO, Asencio C, Mégraud F, 57 Vécsei A, Innerhofer A, Graf U, Binder C, Giczi H, Ham-
Thibonnier M, De Reuse H, Mendz GL. Is Helicobacter pylo- mer K, Bruckdorfer A, Hirschl AM, Makristathis A. Helico-
ri a true microaerophile? Helicobacter 2006; 11: 296-303 [PMID: bacter pylori eradication rates in children upon susceptibil-
16882333 DOI: 10.1111/j.1523-5378.2006.00413.x] ity testing based on noninvasive stool polymerase chain
45 Park SA, Ko A, Lee NG. Stimulation of growth of the human reaction versus gastric tissue culture. J Pediatr Gastroen-
gastric pathogen Helicobacter pylori by atmospheric level of terol Nutr 2011; 53: 65-70 [PMID: 21694538 DOI: 10.1097/
oxygen under high carbon dioxide tension. BMC Microbiol MPG.0b013e318210586d]
2011; 11: 96 [PMID: 21569333 DOI: 10.1186/1471-2180-11-96] 58 Xiong LJ, Tong Y, Wang Z, Mao M. Detection of clarithro-
46 Leszczyńska K, Namiot A, Namiot Z, Leszczyńska JK, Ja- mycin-resistant Helicobacter pylori by stool PCR in children:
koniuk P, Chilewicz M, Namiot DB, Kemona A, Milewski a comprehensive review of literature. Helicobacter 2013; 18:
R, Bucki R. Patient factors affecting culture of Helicobacter 89-101 [PMID: 23067446 DOI: 10.1111/hel.12016]
pylori isolated from gastric mucosal specimens. Adv Med 59 Woo HY, Park DI, Park H, Kim MK, Kim DH, Kim IS, Kim
Sci 2010; 55: 161-166 [PMID: 20639184 DOI: 10.2478/ YJ. Dual-priming oligonucleotide-based multiplex PCR for
v10039-010-0028-1] the detection of Helicobacter pylori and determination of
47 Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shed- clarithromycin resistance with gastric biopsy specimens.
ding of Helicobacter pylori from healthy infected adults. Helicobacter 2009; 14: 22-28 [PMID: 19191892 DOI: 10.1111/
JAMA 1999; 282: 2240-2245 [PMID: 10605976 DOI: 10.1001/ j.1523-5378.2009.00654.x]
jama.282.23.2240] 60 Lehours P, Siffré E, Mégraud F. DPO multiplex PCR as an
48 Kim do H, Jung HM, Hwang YJ, Ahn YS, Mun JS, Myoung alternative to culture and susceptibility testing to detect He-
BH, Park H, Jeong EJ, Im YM, Oh HM, Jeong HY, Park C, licobacter pylori and its resistance to clarithromycin. BMC
Kim HR, Cho EH, Kim HD, Jun YD. [Culture and poly- Gastroenterol 2011; 11: 112 [PMID: 22004003 DOI: 10.1186/14
merase chain reaction of Helicobacter pylori from rectal and 71-230X-11-112]
terminal ileal fluid after polyethylene glycol (colyte) inges- 61 Monno R, Giorgio F, Carmine P, Soleo L, Cinquepalmi V,
tion in healthy adults with positive urea breath test]. Korean J Ierardi E. Helicobacter pylori clarithromycin resistance de-
Gastroenterol 2010; 56: 27-32 [PMID: 20664315 DOI: 10.4166/ tected by Etest and TaqMan real-time polymerase chain reac-
kjg.2010.56.1.27] tion: a comparative study. APMIS 2012; 120: 712-717 [PMID:
49 Agarwal S, Jithendra KD. Presence of Helicobacter pylori 22882260 DOI: 10.1111/j.1600-0463.2012.02896.x]
in subgingival plaque of periodontitis patients with and 62 Schmitt BH, Regner M, Mangold KA, Thomson RB, Kaul
without dyspepsia, detected by polymerase chain reaction KL. PCR detection of clarithromycin-susceptible and -re-
and culture. J Indian Soc Periodontol 2012; 16: 398-403 [PMID: sistant Helicobacter pylori from formalin-fixed, paraffin-
23162336 DOI: 10.4103/0972-124X.100919] embedded gastric biopsies. Mod Pathol 2013; 26: 1222-1227
50 Tsami A, Petropoulou P, Kafritsa Y, Mentis YA, Roma- [PMID: 23579617 DOI: 10.1038/modpathol.2013.48]
Giannikou E. The presence of Helicobacter pylori in dental 63 Cerqueira L, Fernandes RM, Ferreira RM, Oleastro M, Car-
plaque of children and their parents: is it related to their neiro F, Brandão C, Pimentel-Nunes P, Dinis-Ribeiro M,
periodontal status and oral hygiene? Eur J Paediatr Dent 2011; Figueiredo C, Keevil CW, Vieira MJ, Azevedo NF. Validation
12: 225-230 [PMID: 22185245] of a fluorescence in situ hybridization method using pep-
51 Miendje Deyi VY, Burette A, Bentatou Z, Maaroufi Y, Bon- tide nucleic acid probes for detection of Helicobacter pylori
tems P, Lepage P, Reynders M. Practical use of GenoType® clarithromycin resistance in gastric biopsy specimens. J Clin
HelicoDR, a molecular test for Helicobacter pylori detection Microbiol 2013; 51: 1887-1893 [PMID: 23596234 DOI: 10.1128/
and susceptibility testing. Diagn Microbiol Infect Dis 2011; 70: JCM.00302-13]
557-560 [PMID: 21696906 DOI: 10.1016/j.diagmicrobio.2011. 64 González CA, Figueiredo C, Lic CB, Ferreira RM, Pardo ML,
05.002] Ruiz Liso JM, Alonso P, Sala N, Capella G, Sanz-Anquela JM.
52 Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Helicobacter pylori cagA and vacA genotypes as predictors
Deforges L, Soussy CJ, Delchier JC, Megraud F. Evaluation of of progression of gastric preneoplastic lesions: a long-term
a new test, genotype HelicoDR, for molecular detection of an- follow-up in a high-risk area in Spain. Am J Gastroenterol
tibiotic resistance in Helicobacter pylori. J Clin Microbiol 2009; 2011; 106: 867-874 [PMID: 21285949 DOI: 10.1038/ajg.2011.1]
47: 3600-3607 [PMID: 19759218 DOI: 10.1128/JCM.00744-09] 65 Ferreira RM, Machado JC, Letley D, Atherton JC, Pardo ML,
53 Oleastro M, Ménard A, Santos A, Lamouliatte H, Monteiro Gonzalez CA, Carneiro F, Figueiredo C. A novel method for
L, Barthélémy P, Mégraud F. Real-time PCR assay for genotyping the Helicobacter pylori vacA intermediate region
rapid and accurate detection of point mutations conferring directly in gastric biopsy specimens. J Clin Microbiol 2012; 50:
resistance to clarithromycin in Helicobacter pylori. J Clin 3983-3989 [PMID: 23035185 DOI: 10.1128/JCM.02087-12]
Microbiol 2003; 41: 397-402 [PMID: 12517879 DOI: 10.1128/ 66 Hatakeyama M. Anthropological and clinical implications
JCM.41.1.397-402.2003] for the structural diversity of the Helicobacter pylori CagA
oncoprotein. Cancer Sci 2011; 102: 36-43 [PMID: 20942897 81 Kato S, Ozawa K, Konno M, Tajiri H, Yoshimura N, Shimizu
DOI: 10.1111/j.1349-7006.2010.01743.x] T, Fujisawa T, Abukawa D, Minoura T, Iinuma K. Diag-
67 Batista SA, Rocha GA, Rocha AM, Saraiva IE, Cabral MM, nostic accuracy of the 13C-urea breath test for childhood
Oliveira RC, Queiroz DM. Higher number of Helicobacter Helicobacter pylori infection: a multicenter Japanese study.
pylori CagA EPIYA C phosphorylation sites increases the Am J Gastroenterol 2002; 97: 1668-1673 [PMID: 12135016 DOI:
risk of gastric cancer, but not duodenal ulcer. BMC Microbiol 10.1111/j.1572-0241.2002.05825.x]
2011; 11: 61 [PMID: 21435255 DOI: 10.1186/1471-2180-11-61] 82 Kawakami E, Machado RS, Reber M, Patrício FR. 13 C-urea
68 Acosta N, Quiroga A, Delgado P, Bravo MM, Jaramillo C. breath test with infrared spectroscopy for diagnosing helico-
Helicobacter pylori CagA protein polymorphisms and their bacter pylori infection in children and adolescents. J Pediatr
lack of association with pathogenesis. World J Gastroenterol Gastroenterol Nutr 2002; 35: 39-43 [PMID: 12142808 DOI:
2010; 16: 3936-3943 [PMID: 20712055 DOI: 10.3748/wjg.v16. 10.1097/00005176-200207000-00010]
i31.3936] 83 Parente F, Bianchi Porro G. The (13)C-urea breath test for
69 Saez J, Belda S, Santibáñez M, Rodríguez JC, Sola-Vera non-invasive diagnosis of Helicobacter pylori infection:
J, Galiana A, Ruiz-García M, Brotons A, López-Girona E, which procedure and which measuring equipment? Eur J
Girona E, Sillero C, Royo G. Real-time PCR for diagnosing Gastroenterol Hepatol 2001; 13: 803-806 [PMID: 11474309 DOI:
Helicobacter pylori infection in patients with upper gastro- 10.1097/00042737-200107000-00007]
intestinal bleeding: comparison with other classical diag- 84 Guarner J, Kalach N, Elitsur Y, Koletzko S. Helicobacter py-
nostic methods. J Clin Microbiol 2012; 50: 3233-3237 [PMID: lori diagnostic tests in children: review of the literature from
22837325 DOI: 10.1128/JCM.01205-12] 1999 to 2009. Eur J Pediatr 2010; 169: 15-25 [PMID: 19618211
70 Shukla SK, Prasad KN, Tripathi A, Ghoshal UC, Krishnani DOI: 10.1007/s00431-009-1033-x]
N, Nuzhat H. Quantitation of Helicobacter pylori ureC gene 85 Graham DY, Klein PD, Evans DJ, Evans DG, Alpert LC, Ope-
and its comparison with different diagnostic techniques and kun AR, Boutton TW. Campylobacter pylori detected nonin-
gastric histopathology. J Microbiol Methods 2011; 86: 231-237 vasively by the 13C-urea breath test. Lancet 1987; 1: 1174-1177
[PMID: 21624400 DOI: 10.1016/j.mimet.2011.05.012] [PMID: 2883491 DOI: 10.1016/S0140-6736(87)92145-3]
71 Nayak AK, Rose JB. Detection of Helicobacter pylori in sew- 86 Machado RS, Patrício FR, Kawakami E. 13C-urea breath test
age and water using a new quantitative PCR method with to diagnose Helicobacter pylori infection in children aged up
SYBR green. J Appl Microbiol 2007; 103: 1931-1941 [PMID: to 6 years. Helicobacter 2004; 9: 39-45 [PMID: 15156902 DOI:
17953603 DOI: 10.1111/j.1365-2672.2007.03435.x] 10.1111/j.1083-4389.2004.00196.x]
72 Voytek MA, Ashen JB, Fogarty LR, Kirshtein JD, Landa ER. 87 Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Fran-
Detection of Helicobacter pylori and fecal indicator bacteria cois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular
in five North American rivers. J Water Health 2005; 3: 405-422 analysis of the bacterial microbiota in the human stomach.
[PMID: 16459846] Proc Natl Acad Sci USA 2006; 103: 732-737 [PMID: 16407106
73 Jungblut PR, Bumann D, Haas G, Zimny-Arndt U, Hol- DOI: 10.1073/pnas.0506655103]
land P, Lamer S, Siejak F, Aebischer A, Meyer TF. Com- 88 Vaira D, Gatta L, Ricci C, Di Mario F, Lanzini A. Accuracy
parative proteome analysis of Helicobacter pylori. Mol of urea breath tests tablets after 10 minutes compared with
Microbiol 2000; 36: 710-725 [PMID: 10844659 DOI: 10.1046/ standard 30 minutes to diagnose and monitoring Heli-
j.1365-2958.2000.01896.x] cobacter pylori infection: a randomized controlled trial. J
74 Baik SC, Kim KM, Song SM, Kim DS, Jun JS, Lee SG, Song Clin Gastroenterol 2009; 43: 693-694 [PMID: 19398928 DOI:
JY, Park JU, Kang HL, Lee WK, Cho MJ, Youn HS, Ko GH, 10.1097/MCG.0b013e318193e487]
Rhee KH. Proteomic analysis of the sarcosine-insoluble outer 89 Slater C, Preston T, Weaver LT. Is there an advantage in
membrane fraction of Helicobacter pylori strain 26695. J normalising the results of the Helicobacter pylori [13C]urea
Bacteriol 2004; 186: 949-955 [PMID: 14761989 DOI: 10.1128/ breath test for CO2 production rate in children? Isotopes
JB.186.4.949-955.2004] Environ Health Stud 2004; 40: 89-98 [PMID: 15085988 DOI:
75 Sabarth N, Lamer S, Zimny-Arndt U, Jungblut PR, Meyer 10.1080/10256010310001621164]
TF, Bumann D. Identification of surface proteins of Heli- 90 Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R,
cobacter pylori by selective biotinylation, affinity purifica- Torres J. 13C-urea breath test for the diagnosis of Helico-
tion, and two-dimensional gel electrophoresis. J Biol Chem bacter pylori infection in children: a systematic review and
2002; 277: 27896-27902 [PMID: 12023975 DOI: 10.1074/jbc. meta-analysis. Helicobacter 2011; 16: 327-337 [PMID: 21762274
M204473200] DOI: 10.1111/j.1523-5378.2011.00863.x]
76 Bumann D, Aksu S, Wendland M, Janek K, Zimny-Arndt 91 Mégraud F. Comparison of non-invasive tests to detect Heli-
U, Sabarth N, Meyer TF, Jungblut PR. Proteome analysis of cobacter pylori infection in children and adolescents: results
secreted proteins of the gastric pathogen Helicobacter py- of a multicenter European study. J Pediatr 2005; 146: 198-203
lori. Infect Immun 2002; 70: 3396-3403 [PMID: 12065478 DOI: [PMID: 15689908 DOI: 10.1016/j.jpeds.2004.10.044]
10.1128/IAI.70.7.3396-3403.2002] 92 Pacheco SL, Ogata SK, Machado RS, Patrício FR, Pardo ML,
77 Lin LL, Huang HC, Juan HF. Discovery of biomarkers for Kawakami E. Diagnosis of Helicobacter pylori infection by
gastric cancer: a proteomics approach. J Proteomics 2012; 75: means of reduced-dose ¹³C-urea breath test and early sam-
3081-3097 [PMID: 22498886 DOI: 10.1016/j.jprot.2012.03.046] pling of exhaled breath. J Pediatr Gastroenterol Nutr 2013;
78 Vitoriano I, Saraiva-Pava KD, Rocha-Gonçalves A, Santos 57: 607-611 [PMID: 23783010 DOI: 10.1097/MPG.0b013e
A, Lopes AI, Oleastro M, Roxo-Rosa M. Ulcerogenic Helico- 3182a02608]
bacter pylori strains isolated from children: a contribution to 93 Queiroz DM, Saito M, Rocha GA, Rocha AM, Melo FF,
get insight into the virulence of the bacteria. PLoS One 2011; 6: Checkley W, Braga LL, Silva IS, Gilman RH, Crabtree JE.
e26265 [PMID: 22039453 DOI: 10.1371/journal.pone.0026265] Helicobacter pylori infection in infants and toddlers in South
79 Graham DY, Klein PD. Accurate diagnosis of Helico- America: concordance between [13C]urea breath test and
bacter pylori. 13C-urea breath test. Gastroenterol Clin North monoclonal H. pylori stool antigen test. J Clin Microbiol 2013;
Am 2000; 29: 885-93, x [PMID: 11190073 DOI: 10.1016/ 51: 3735-3740 [PMID: 24006009 DOI: 10.1128/JCM.01752-13]
S0889-8553(05)70156-4] 94 Olafsson S, Patel B, Jackson C, Cai J. Helicobacter pylori
80 Gisbert JP, Pajares JM. Review article: 13C-urea breath test breath testing in an open access system has a high rate of
in the diagnosis of Helicobacter pylori infection -- a critical potentially false negative results due to protocol violations.
review. Aliment Pharmacol Ther 2004; 20: 1001-1017 [PMID: Helicobacter 2012; 17: 391-395 [PMID: 22967123 DOI: 10.1111/
15569102 DOI: 10.1111/j.1365-2036.2004.02203.x] j.1523-5378.2012.00964.x]
95 Velayos B, Fernández-Salazar L, Pons-Renedo F, Muñoz 109 Braden B. Diagnosis of Helicobacter pylori infection. BMJ
MF, Almaraz A, Aller R, Ruíz L, Del Olmo L, Gisbert JP, 2012; 344: e828 [PMID: 22368293 DOI: 10.1136/bmj.e828]
González-Hernández JM. Accuracy of urea breath test 110 Tonkic A, Tonkic M, Lehours P, Mégraud F. Epidemiology
performed immediately after emergency endoscopy in pep- and diagnosis of Helicobacter pylori infection. Helicobacter
tic ulcer bleeding. Dig Dis Sci 2012; 57: 1880-1886 [PMID: 2012; 17 Suppl 1: 1-8 [PMID: 22958148 DOI: 10.1111/
22453995 DOI: 10.1007/s10620-012-2096-5] j.1523-5378.2012.00975.x]
96 Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel 111 Vale FF, Encarnação P, Vítor JM. A new algorithm for clus-
M, Sinclair P. International consensus recommendations on ter analysis of genomic methylation: the Helicobacter pylori
the management of patients with nonvariceal upper gastro- case. Bioinformatics 2008; 24: 383-388 [PMID: 18086685 DOI:
intestinal bleeding. Ann Intern Med 2010; 152: 101-113 [PMID: 10.1093/bioinformatics/btm621]
20083829 DOI: 10.7326/0003-4819-152-2-201001190-00009] 112 Vale FF, Mégraud F, Vítor JM. Geographic distribution of
97 Wardi J, Shalev T, Shevah O, Boaz M, Avni Y, Shirin H. A methyltransferases of Helicobacter pylori: evidence of hu-
rapid continuous-real-time 13C-urea breath test for the de- man host population isolation and migration. BMC Microbiol
tection of Helicobacter pylori in patients after partial gastrec- 2009; 9: 193 [PMID: 19737407 DOI: 10.1186/1471-2180-9-193]
tomy. J Clin Gastroenterol 2012; 46: 293-296 [PMID: 22395063 113 Vitoriano I, Rocha-Gonçalves A, Carvalho T, Oleastro
DOI: 10.1097/MCG.0b013e31823eff09] M, Calado CR, Roxo-Rosa M. Antigenic diversity among
98 Cirak MY, Akyön Y, Mégraud F. Diagnosis of Helicobacter Portuguese clinical isolates of Helicobacter pylori. Heli-
pylori. Helicobacter 2007; 12 Suppl 1: 4-9 [PMID: 17727453 cobacter 2011; 16: 153-168 [PMID: 21435094 DOI: 10.1111/
DOI: 10.1111/j.1523-5378.2007.00542.x] j.1523-5378.2011.00825.x]
99 Choi J, Kim CH, Kim D, Chung SJ, Song JH, Kang JM, Yang 114 McNulty CA, Lehours P, Mégraud F. Diagnosis of Helico-
JI, Park MJ, Kim YS, Yim JY, Lim SH, Kim JS, Jung HC, Song bacter pylori Infection. Helicobacter 2011; 16 Suppl 1: 10-18
IS. Prospective evaluation of a new stool antigen test for the [PMID: 21896080 DOI: 10.1111/j.1523-5378.2011.00875.x]
detection of Helicobacter pylori, in comparison with histol- 115 Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka
ogy, rapid urease test, (13)C-urea breath test, and serology. M, Shimoyama T, Graham DY. Evaluation of the effects
J Gastroenterol Hepatol 2011; 26: 1053-1059 [PMID: 21362044 of strain-specific antigen variation on the accuracy of se-
DOI: 10.1111/j.1440-1746.2011.06705.x] rologic diagnosis of Helicobacter pylori infection. J Clin
100 Chehter EZ, Bacci MR, Fonseca FL, Gonçalves JA, Buchalla G, Microbiol 2003; 41: 1480-1485 [PMID: 12682133 DOI: 10.1128/
Shiraichi SA, Mariano RC. Diagnosis of the infection by the JCM.41.4.1480-1485.2003]
Helicobacter pylori through stool examination: method stan- 116 Khalifeh Gholi M, Kalali B, Formichella L, Göttner G,
dardization in adults. Clin Biochem 2013; 46: 1622-1624 [PMID: Shamsipour F, Zarnani AH, Hosseini M, Busch DH, Shirazi
23769952 DOI: 10.1016/j.clinbiochem.2013.05.071] MH, Gerhard M. Helicobacter pylori FliD protein is a highly
101 Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclo- sensitive and specific marker for serologic diagnosis of H.
nal stool antigen test for the diagnosis of H. pylori infection: pylori infection. Int J Med Microbiol 2013; 303: 618-623 [PMID:
a systematic review and meta-analysis. Am J Gastroenterol 24103649]
2006; 101: 1921-1930 [PMID: 16780557 DOI: 10.1111/ 117 Talebkhan Y, Ebrahimzadeh F, Esmaeili M, Zamaninia
j.1572-0241.2006.00668.x] L, Nahvijoo A, Khedmat H, Fereidooni F, Mohagheghi
102 Sato M, Shimoyama T, Takahashi R, Kajiyama H, Sano Y, MA, Mohammadi M. Helicobacter pylori Omp18 and its
Sakaedani N, Kato A, Hirata H, Fukuda Y. Characterization application in serologic screening of infection. Curr Mi-
and usefulness of stool antigen tests using a monoclonal crobiol 2011; 62: 325-330 [PMID: 20652254 DOI: 10.1007/
antibody to Helicobacter pylori catalase. J Gastroenterol Hepa- s00284-010-9694-2]
tol 2012; 27 Suppl 3: 23-28 [PMID: 22486867 DOI: 10.1111/ 118 Stege PW, Raba J, Messina GA. Online immunoaffinity
j.1440-1746.2012.07066.x] assay-CE using magnetic nanobeads for the determination
103 Suzuki N, Wakasugi M, Nakaya S, Okada K, Mochida R, of anti-Helicobacter pylori IgG in human serum. Electro-
Sato M, Kajiyama H, Takahashi R, Hirata H, Ezure Y, Koga phoresis 2010; 31: 3475-3481 [PMID: 20922758 DOI: 10.1002/
Y, Fukuda Y, Shimoyama T. Production and application of elps.201000123]
new monoclonal antibodies specific for a fecal Helicobacter 119 Karakus C, Salih BA. Comparison of the lateral flow im-
pylori antigen. Clin Diagn Lab Immunol 2002; 9: 75-78 [PMID: munoassays (LFIA) for the diagnosis of Helicobacter pylori
11777832] infection. J Immunol Methods 2013; 396: 8-14 [PMID: 23994110
104 Iranikhah A, Ghadir MR, Sarkeshikian S, Saneian H, Heiari DOI: 10.1016/j.jim.2013.08.010]
A, Mahvari M. Stool antigen tests for the detection of He- 120 Toyoda K, Furusyo N, Ihara T, Ikezaki H, Urita Y, Hayashi J.
licobacter pylori in children. Iran J Pediatr 2013; 23: 138-142 Serum pepsinogen and Helicobacter pylori infection--a Japa-
[PMID: 23724172] nese population study. Eur J Clin Microbiol Infect Dis 2012; 31:
105 Moon DI, Shin EH, Oh HG, Oh JS, Hong S, Chung Y, 2117-2124 [PMID: 22354521 DOI: 10.1007/s10096-011-1543-0]
Kim O. Usefulness of a Helicobacter pylori stool antigen 121 Adamsson I, Edlund C, Nord CE. Microbial ecology and
test for diagnosing H. pylori infected C57BL/6 mice. Lab treatment of Helicobacter pylori infections: review. J Che-
Anim Res 2013; 29: 27-32 [PMID: 23573105 DOI: 10.5625/ mother 2000; 12: 5-16 [PMID: 10768510]
lar.2013.29.1.27] 122 Kabir S. Detection of Helicobacter pylori DNA in feces
106 Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, and saliva by polymerase chain reaction: a review. Heli-
Mégraud F, Zerbib F, Raymond J, Fauchère JL. Comparative cobacter 2004; 9: 115-123 [PMID: 15068412 DOI: 10.1111/
evaluation of 29 commercial Helicobacter pylori serologi- j.1083-4389.2004.00207.x]
cal kits. Helicobacter 2013; 18: 169-179 [PMID: 23316886 DOI: 123 Souto R, Colombo AP. Detection of Helicobacter pylori by
10.1111/hel.12030] polymerase chain reaction in the subgingival biofilm and sa-
107 Mégraud F. The most important diagnostic modalities for liva of non-dyspeptic periodontal patients. J Periodontol 2008;
Helicobacter pylori, now and in the future. Eur J Gastroen- 79: 97-103 [PMID: 18166098 DOI: 10.1902/jop.2008.070241]
terol Hepatol 2012; 9 Suppl 1: S13-S5; discussion S15 [PMID: 124 Chaudhry S, Idrees M, Izhar M, Butt AK, Khan AA. Simul-
22498901 DOI: 10.1097/00042737-201204001-00004] taneous amplification of two bacterial genes: more reliable
108 Rubicz R, Leach CT, Kraig E, Dhurandhar NV, Duggirala R, method of Helicobacter pylori detection in microbial rich
Blangero J, Yolken R, Göring HH. Genetic factors influence dental plaque samples. Curr Microbiol 2011; 62: 78-83 [PMID:
serological measures of common infections. Hum Hered 2011; 20512648 DOI: 10.1007/s00284-010-9662-x]
72: 133-141 [PMID: 21996708 DOI: 10.1159/000331220] 125 Abrante L, Reyes N, García-Amado MA, Suárez P, Romero
R, Michelangeli F, Contreras M. [Diagnosis of Helicobacter urease test, PCR and blood serology: a prospective study. Int
pylori infection by PCR in gastric juice and gastroesopha- J Pediatr Otorhinolaryngol 2011; 75: 568-572 [PMID: 21324534
geal biopsies from dyspeptic patients]. Invest Clin 2012; 53: DOI: 10.1016/j.ijporl.2011.01.021]
168-177 [PMID: 22978049] 128 Petersen RF, Harrington CS, Kortegaard HE, On SL. A PCR-
126 Vilarinho S, Guimarães NM, Ferreira RM, Gomes B, Wen DGGE method for detection and identification of Campylo-
X, Vieira MJ, Carneiro F, Godinho T, Figueiredo C. Helico- bacter, Helicobacter, Arcobacter and related Epsilobacteria
bacter pylori colonization of the adenotonsillar tissue: fact or and its application to saliva samples from humans and
fiction? Int J Pediatr Otorhinolaryngol 2010; 74: 807-811 [PMID: domestic pets. J Appl Microbiol 2007; 103: 2601-2615 [PMID:
20452684 DOI: 10.1016/j.ijporl.2010.04.007] 17916160 DOI: 10.1111/j.1365-2672.2007.03515.x]
127 Abdel-Monem MH, Magdy EA, Nour YA, Harfoush RA, 129 del Pozo García AJ, Gisbert JP. Is the string test a useful al-
Ibreak A. Detection of Helicobacter pylori in adenotonsillar ternative to gastroscopy with biopsy for H. pylori identifica-
tissue of children with chronic adenotonsillitis using rapid tion? Rev Esp Enferm Dig 2006; 98: 542-549 [PMID: 17022703]